Analyst Ratings for Biogen (BiIB)
BiIB Rating Summary
BiIB Price Target Summary
- Highest: $300.00 (Oppenheimer)
- Lowest: $157.00 (HSBC)
- Average: $230.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$230.14 (+5.3%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$230.14 (+5.3%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Wolfe Research | Alexandria Hammond | Upgrade | Outperform (Peerperform) |
300.00 (N/A) |
208.87 (218.50) |
4.61% | Details |
| 7/13/2026 | Truist Securities | Danielle Brill | Upgrade | Buy (Hold) |
235.00 (N/A) |
199.15 (218.50) |
9.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
